World’s First Brain Implant for Epilepsy Control
Oran Knowlson, a UK teenager, became the first person to receive a brain implant for epilepsy control, reducing his seizures by 80%. Epilepsy, often causing…
Social Sector
Microschool
Premium Content! You need General Studies (GS) subscription to access this content. Join now to unlock premium content. JOIN NOW
IIIT-Delhi Wins Prize for Antimicrobial Resistance Project
Premium Content! You need General Studies (GS) subscription to access this content. Join now to unlock premium content. JOIN NOW
Can AI Detect Parkinson’s Disease Early?
A groundbreaking study from University College London and University Medical Center Goettingen, published in Nature Communications, describes a new AI-based blood test that can detect…
Japan On High Alert as STSS Infections Surge
Premium Content! You need General Studies (GS) subscription to access this content. Join now to unlock premium content. JOIN NOW
Gavi Supports Rabies Vaccines for Global Eradication Efforts
Premium Content! You need General Studies (GS) subscription to access this content. Join now to unlock premium content. JOIN NOW
Landmark Paper Sparks Decades of AIDS Research
Dr. Michael Gottlieb’s 1981 research on pneumocystis pneumonia led to the first identification of AIDS. Despite 50 years of study, HIV’s high genetic diversity and…
IIT-M and NASA Study Pathogens on ISS
The study by IIT-M and NASA on the ISS focused on Enterobacter bugandensis, a drug-resistant pathogen. This bacterium, part of the ESKAPE group, is highly…
Is Donanemab a Breakthrough Treatment for Alzheimer’s?
Donanemab, developed by Eli Lilly, is an experimental antibody treatment targeting N3pG amyloid to slow cognitive decline in Alzheimer’s patients. Recently, an FDA advisory group…
